STOCK TITAN

Schedule 13G: Adage Capital discloses 5.34% passive stake in Adagio Medical

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Adage Capital Management, L.P., together with individuals Robert Atchinson and Phillip Gross, reported beneficial ownership of 821,261 shares of Adagio Medical Holdings, Inc. common stock, representing 5.34% of the class. The percentage was calculated using 15,381,565 shares outstanding as of May 7, 2025, per the company quarterly report filed May 15, 2025. The Schedule 13G shows shared voting and shared dispositive power over all 821,261 shares and includes a certification that the securities were acquired and are held in the ordinary course of business and not to influence control. The filing lists the issuer office in Laguna Hills, CA, and includes a joint filing agreement as Exhibit 99.1.

Positive

  • Reported beneficial ownership exceeds 5%, at 821,261 shares (5.34%), meeting materiality thresholds that require public disclosure
  • Filing is on Schedule 13G with a certification that the shares are held in the ordinary course and not to influence control, indicating passive intent

Negative

  • None.

Insights

TL;DR: Adage reports a passive 5.34% stake (821,261 shares) in Adagio, disclosed on Schedule 13G.

The filing documents a >5% position held by Adage Capital Management, L.P., with shared voting and dispositive power over 821,261 shares, calculated on 15,381,565 shares outstanding as of May 7, 2025. Because this is a Schedule 13G with a certification that the stake is held in the ordinary course and not to influence control, it is presented as a passive, reportable ownership position rather than an active control attempt.

TL;DR: The Schedule 13G filing signals a reportable, passive substantial holder with shared authority over the position.

The statement names Adage Capital Management, L.P. and two individuals as reporting persons and shows shared voting and dispositive power for all reported shares. The filing includes the required certification and a joint filing agreement (Exhibit 99.1). The use of Schedule 13G and the explicit certification indicate the reporting persons characterize the position as passive under applicable rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake in Adagio Medical (ADGM) did Adage report?

Adage reported beneficial ownership of 821,261 shares, equal to 5.34% of Adagio Medical common stock.

How was the 5.34% ownership calculated for ADGM?

The percentage uses an aggregate of 15,381,565 shares outstanding as of May 7, 2025, per the company's quarterly report filed May 15, 2025.

Which reporting persons filed the Schedule 13G for ADGM?

The filing was made by Adage Capital Management, L.P. and two individuals: Robert Atchinson and Phillip Gross.

Does the filing indicate Adage seeks to influence control of ADGM?

No. The Schedule 13G includes a certification that the securities were acquired and are held in the ordinary course of business and not to change or influence control.

What voting and dispositive powers are reported?

The filing reports 0 shares with sole voting or dispositive power and 821,261 shares with shared voting and shared dispositive power.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Adage Capital Management, L.P.
Signature:/s/ Robert Atchinson
Name/Title:By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Date:08/12/2025
Robert Atchinson
Signature:/s/ Robert Atchinson
Name/Title:Robert Atchinson, individually
Date:08/12/2025
Phillip Gross
Signature:/s/ Phillip Gross
Name/Title:Phillip Gross, individually
Date:08/12/2025
Exhibit Information

Exhibit 99.1: Joint Filing Agreement